Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer

Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer

IntroductionProstate cancer (PCa) is the second most frequent cancer diagnosis in men and the fifth leading cause of death worldwide. Prostate Specific Membrane Antigen (PSMA) and Gastrin Releasing Peptide (GRP) receptors are overexpressed in PCa. In this study, we have developed iron oxide nanopart...

Full description

Bibliographic Details
Main Authors: Danae Efremia Bajwa, Evangelia-Alexandra Salvanou, Maria Theodosiou, Theodora S. Koutsikou, Eleni K. Efthimiadou, Penelope Bouziotis, Christos Liolios
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Nuclear Medicine
Subjects:
prostate cancer
PSMA
bombesin
bispecific heterodimers
iron oxide nanoparticles
99mTc
Online Access:https://www.frontiersin.org/articles/10.3389/fnume.2023.1184309/full

Internet

https://www.frontiersin.org/articles/10.3389/fnume.2023.1184309/full

Similar Items